Skip to main content

Table 2 Summary of consensus status for individual questioning items

From: Working towards consensus on methods used to elicit participant-reported safety data in uncomplicated malaria clinical drug studies: a Delphi technique study

Items rated

Consensus status

Section A

General questions about AEs

Round 2

Round 3

 Explicit question about change in health (e.g. ‘Have you observed any change or new complaint since your last visit/in the past x days [trial-specific time scale]?’)

Optimal

 

 Question implying causality (e.g. ‘Did your child experience any side effect from the drug since your last visit/in the past x days [trial-specific time scale]?’)

 

Not optimal

 General question about feeling (e.g. ‘How have you [has your child] been feeling since your last visit/in the past x days [trial-specific time scale]?)

 

No consensus

 General question about past adverse reactions to treatments (e.g. ‘Have you ever reacted badly to a drug or vaccine’)

 

No consensus

 General question about rating any change in health (e.g. ‘How do you rate your state of health after taking the study medicine?’)

 

No consensus

Structured questions about body parts, systems or function (e.g. ‘Have you experienced a problem with your head, chest, breathing….?’ or ‘Have you experienced fever, headache, rash….?’)

Round 2

Round 3

Nose

 

Optimal

Lungs/breathing

 

Optimal

Head

 

Optimal

Ears

 

No consensus

Throat

 

No consensus

Eyes

 

No consensus

Chest

 

No consensus

Heart

 

No consensus

Lymphatic system

 

No consensus

Nervous system

 

No consensus

Tiredness/fatigue/weakness/lethargy

 

Optimal

Muscle pain

 

Optimal

Joint pain

 

Optimal

Abdominal pain

 

Optimal

Mood/behavioural change

 

Optimal

Allergic skin rash (e.g. some forms of urticaria)

 

Optimal

Skin abnormalities

 

Optimal

Dizziness

 

Optimal

Vision/sight problem

 

Optimal

Change in urine colour

 

Optimal

Palpitations

 

Optimal

Confusion

 

Optimal

Jaundice/icterus

 

Optimal

Oculogyric crisis

 

Not optimal

Photosensitivity (sensitivity to light)

 

Optimal

Spontaneous bleeding

 

Optimal

Constipation

 

Optimal

Blisters (on skin or mucous membrane)

 

Optimal

Hallucinations

 

Optimal

Headache

Optimal

 

Fever

Optimal

 

Cough

Optimal

 

Loss of appetite

Optimal

 

Vomiting

Optimal

 

Nausea

Optimal

 

Diarrhoea

Optimal

 

Itching (no rash)

Optimal

 

Peeling skin

Optimal

 

Tinnitus (ringing in the ears)/hearing problem

Optimal

 

Sleep disturbance/nightmares

Optimal

 

Involuntary movements (e.g. rigors/convulsions/seizures)

Optimal

 

Wheezing/difficulty breathing

Optimal

 

Non-allergic skin rash (e.g. scabies)

 

No consensus

Posturing

 

No consensus

Pallor

 

No consensus

Change in walking (gait disturbance)

 

No consensus

In infants

  

Eating/drinking/feeding less than normal

Optimal

 

Irritable

 

Optimal

Abnormal sucking, if breastfed

 

Optimal

Crying more than normal

 

Optimal

Difficult to arouse

Optimal

 

In pregnant women

  

Baby movements less than normal

 

Optimal

Vaginal bleeding

 

Optimal

Increased uterine contractions, more than normal

Optimal

 

Pictorial questioning tools about AEs

Round 2

Round 3

Using photographs, drawings or pictures of the following signs and symptoms

  

Mucous membrane blisters

 

Optimal

Skin rash

 

Optimal

Headache

 

No consensus

Fever

 

No consensus

Loss of appetite

 

No consensus

Diarrhoea

 

No consensus

Jaundice/icterus

 

No consensus

Joint pain

 

No consensus

Pruritus

 

No consensus

Using photographs, drawings or pictures of the following body parts

Respiratory system

 

No consensus

Gastrointestinal tract

 

No consensus

Central nervous system

 

No consensus

Skin

 

No consensus

Other

Round 2

Round 3

Whole body outline

 

No consensus

Collecting AE reports using mobile phones

 

Optimal

Collecting AE reports using patient diaries

 

Optimal

Using an archive of visual analogue scales from day 0 throughout all the follow-ups to measure potential AEs and any change in the occurrence of these events

 

Optimal

Openly engaging participants to discuss any concerns they have

 

Optimal

Keeping an archive of digital photographs of AEs

Optimal

 

Collecting AE reports using group discussions

 

No consensus

Using flip charts, with a picture on one side for the participant and a written question for the investigator on the reverse side (to reduce investigator variability)

 

No consensus

Using video footage on smartphones or tablets to show how some AEs which are difficult to depict on still images may manifest e.g. seizure activity

 

No consensus

Section B

  

General questions about previous or concomitant medication (non-study druG)

Round 2

Round 3

General questions about the use of non-study medications (e.g. ‘Have you taken any medications since your last visit/in the past x days [trial-specific time scale]?’).

Optimal

 

Structured questions about previous or concomitant medication (non-study drug)

Round 2

Round 3

Questions about the source of medicines (e.g. ‘Have you received any medication from a traditional healer since you were last seen here?’):

  

Medicine obtained from another health facility

Optimal

 

Medicine obtained from a drug shop, pharmacy, chemical seller, the market (or equivalent)

Optimal

 

Medicine obtained from a traditional healer, informal doctor (or equivalent)

Optimal

 

Medicines already available in the home (from previous treatment courses).

Optimal

 

Medicines obtained from family and/or friends

 

Optimal

Collecting and using naturally occurring herbs/remedies

Optimal

 

Structured questions about treatment class or specified indication

  

Analgesics/anti-inflammatory drug

 

Optimal

Antibiotics

 

Optimal

Antihistamines

 

Optimal

Anti-malarial

 

Optimal

Vitamins

 

No consensus

Other

Round 2

Round 3

Asking about individual treatments by name according to what is known to be locally relevant

 

Optimal

Pictorial and/or other physical tools to question about previous or concomitant medication (non-study druG)

Round 2

Round 3

Showing photographs or drawings of commonly used drugs or drug packets

 

Optimal

Showing samples of commonly used drugs or drug packets

 

Optimal

Showing photographs or drawings of commonly used herbs/traditional remedies

 

Optimal

Asking participants to bring any non-study medication they may have taken before and/or during the trial/study to scheduled visits for a physical inspection

 

Optimal

Showing samples of commonly used herbs/traditional remedies

 

No consensus

  1. Summary of consensus status for individual questioning items rated for relevance, importance and feasibility for asking participants in uncomplicated malaria clinical trials/studies about adverse events and non-study medication